Latest updates for Tranexamic A...

Fresh curated links around Tranexamic A... are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Extended oral tranexamic acid had similar pain scores vs. placebo
  • Clinical Conundrum: What Is the Role of TXA in Dysfunctional Uterine Bleeding?
  • FX activator may help with bleeding control in hemophilia A and B: Trials

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

healio.com /1 month ago

Extended oral tranexamic acid had similar pain scores vs. placebo

NEW ORLEANS — Results presented here showed no differences in pain scores, opioid consumption or functional outcomes among patients undergoing total knee arthroplasty who received...

Read source
rebelem.com /1 month ago

Clinical Conundrum: What Is the Role of TXA in Dysfunctional Uterine Bleeding?

There are a number of accepted treatments for dysfunctional uterine bleeding (DUB) endometrial ablation and hysterectomy as well as medical treatments like hormonal therapy, NSAIDs...

Read source
hemophilianewstoday.com /1 month ago

FX activator may help with bleeding control in hemophilia A and B: Trials

Bemiltenase alfa, an experimental factor X (FX) activator, helped with on-demand bleeding control for people with hemophilia A and B who had developed inhibitors against standard f...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Tranexamic A...

rebelem.com

Recent coverage from public sources
Public source

hemophilianewstoday.com

Recent coverage from public sources
Public source

healio.com

Recent coverage from public sources
Public source